Skip to main content

Table 3 Detailed results for the parallel organs. Statistical significance was tested for each parallel organ group in comparison with the planning system that achieved lowest averaged mean dose (bold). Any 0.01 ≤ p ≤ 0.05 is indicated with a *, and p ≤ 0.01 is indicated with **

From: Planning comparison of five automated treatment planning solutions for locally advanced head and neck cancer

 

AIO

AP

RP1

RP2

RS

Mean ± SD

Rank± SD

Mean ± SD

Rank ±SD

Mean ± SD

Rank ±SD

Mean ± SD

Rank ±SD

Mean ± SD

Rank ±SD

(Gy)

 

(Gy)

 

(Gy)

 

(Gy)

 

(Gy)

 

OralCavity

36.1 ± 16.8 **

2.56 ± 1.21

33.8 ± 17.8*

1.63 ± 0.62

34.1 ± 16.7**

1.81 ± 0.75

36.3 ± 16.2**

2.75 ± 1.34

31.3 ± 17.6

1.06 0.25

Parotid

21.9 ± 6.3

1.31 ± 0.6

21.2 ± 5.9

1.19 ± 0.40

21.6 ± 6.3

1.25 ± 0.45

22.8 ± 6.2

1.50 ± 0.73

21.4 ± 6.2

1.19 ± 0.54

Submand. Glands

35.2 ± 8.4

1.94 ± 1.34

33.6 ± 10.8

1.44 ± 0.81

38.2 ± 7.0 **

2.88 ± 1.41

35.5 ± 9.3

1.88 ± 1.09

36.9 ± 7.6*

2.38 ± 1.15

UAT

38.8 ± 9.3

1.49 ± 0.37

39.3 ± 9.4

1.86 ± 0.64

43.4 ± 7.6**

2.99 ± 1.01

39.7 ± 8.9

1.89 ± 0.7

40.4 ± 8.4

2.00 ± 0.70

Average

 

1.83 ± 1.06*

 

1.53 ± 0.67

 

2.23 ± 1.20**

 

2.00 ± 1.08*

 

1.66 ± 0.91

  1. Abbreviations: AIO automatic interactive optimizer, AP auto-planning, RP RapidPlan, RS Raystation, SD standard deviation, UAT upper aerodigestve tract